Lupus Ventures
Lupus Ventures (dba “The Lupus Venture Fund”) is the venture investment fund of the Lupus Research Alliance. The Fund...
Search Results
You searched for: lupus nephritis
Results found: 1120
“Failure to Appropriately Digest” as a new model of lupus pathogenesis
Defining the determinants of lupus progression and cancerous transformation
Scleroderma
Scleroderma is a connective tissue disease that involves changes in the skin, blood vessels, muscles, and internal organs. It...
SLEDAI
SLEDAI stands for Systemic Lupus Erythematosus Disease Activity Index. The widely used tool measures lupus activity including symptoms, lab results and...
Psychosis
Psychosis is a loss of contact with reality, possibly including hallucinations or delusions. While neuropsychiatric manifestations are fairly common...
A Novel CART Cell Selectively Targeting Age-Associated B Cells to Treat Lupus
Preclinical study
Donor-Advised Fund (DAF)
A donor-advised fund, or DAF, is an investment account for supporting charitable organizations. Contributing cash, securities, or other assets...
Lupus Research Alliance designa a Albert Roy como presidente y director ejecutivo
NUEVA YORK, NY. 10 de agosto de 2022. Lupus Research Alliance (LRA) se complace en anunciar el nombramiento de...
LRA’s Virtual Annual Conference Brings Together Top Lupus Researchers for Dynamic Scientific Exchange
October 28, 2021
Two-day meeting focuses on sharing latest news and generating new scientific ideas
The Lupus Research Alliance (LRA) held...
Lupus Research Alliance Announces Translational Research Grants to Speed Development of New Treatments
NEW YORK, NY – January 10. Can “borrowed” drugs for treating other diseases protect the skin in patients with...
New Phase 3 Study Shows that Gazyva® (obinutuzumab) Significantly Reduces Lupus Disease Activity in SLE
A new Phase 3 study published in the New England Journal of Medicine found that Gazyva® (obinutuzumab) significantly reduced disease...